Eperythrozoonosis (Mycoplasma - swine)

Eperythrozoonosis is an infectious blood disease of swine caused by the bacterium Mycoplasma suis, formerly classified as Eperythrozoon suis. This organism attaches to the surface of red blood cells, leading to their premature destruction and causing varying degrees of anemia in affected pigs. The disease represents one of the most economically significant hematologic disorders in modern swine production, affecting pigs across all age groups and production stages worldwide.

The condition occurs globally wherever pigs are raised commercially or in small-scale operations. Prevalence varies significantly by region, management practices, and diagnostic surveillance intensity, with some herds showing subclinical infection rates exceeding fifty percent while others remain free of the organism. Both domestic pigs and wild boar populations can harbor the infection, creating potential reservoirs for disease transmission to commercial swine operations. The organism persists in carrier animals for extended periods, often for the lifetime of the pig, making eradication from infected herds extremely challenging.

The economic and welfare impact of eperythrozoonosis extends beyond direct mortality losses. Subclinical infections reduce feed efficiency and growth rates, while clinical disease causes significant morbidity requiring treatment intervention. Reproductive impacts include increased embryonic death, reduced litter sizes, and compromised piglet viability when sows experience acute infection during pregnancy. The disease also increases susceptibility to secondary infections by compromising immune function, amplifying its overall impact on herd health and productivity.

Eperythrozoonosis is treatable when diagnosed promptly, and affected pigs can recover with appropriate antimicrobial therapy and supportive care. However, treatment does not eliminate the carrier state, and recovered animals continue to harbor the organism. Early detection through clinical observation and diagnostic testing enables timely intervention, improving outcomes for individual animals and reducing transmission within the herd. Understanding the disease dynamics and implementing appropriate biosecurity measures remain essential components of effective eperythrozoonosis management in swine operations.

The primary cause of eperythrozoonosis is infection with Mycoplasma suis, a small, pleomorphic bacterium that lacks a cell wall and attaches directly to the outer membrane of red blood cells. This organism was previously classified in the genus Eperythrozoon but has been reclassified based on genetic analysis into the Mycoplasma genus. The bacterium cannot survive long outside the host and requires direct transmission through blood contact for spread between animals. Once attached to erythrocytes, the organism damages the cell membrane, marking the cells for destruction by the pig's own immune system.

While no specific genetic predisposition to infection has been identified, individual variation in immune competence affects disease expression significantly. Pigs with robust immune systems may carry the organism subclinically, while those with compromised immunity develop clinical disease. Certain breeding lines may show increased or decreased susceptibility based on overall immune function genetics, though specific genes associated with eperythrozoonosis resistance have not been definitively characterized. Young pigs inherit passive immunity through colostrum, providing temporary protection until their own immune systems mature.

Environmental and management factors play crucial roles in disease transmission and clinical expression. High-density housing increases contact rates between infected and susceptible animals. Poor sanitation allows survival of blood-contaminated materials that can serve as fomites. Concurrent stressors including temperature extremes, transportation, mixing of animal groups, and nutritional deficiencies suppress immune function and trigger clinical disease in carrier animals. Biting insects and lice serve as mechanical vectors, transferring infected blood between pigs, with populations of these arthropods increasing during warm months.

Several risk factors predispose pigs to clinical eperythrozoonosis beyond simple exposure to the organism. Young pigs following loss of maternal immunity, sows during the periparturient period, and pigs experiencing concurrent infections face elevated risk. Surgical procedures including castration, tail docking, and ear notching create opportunities for blood-borne transmission if equipment is not properly disinfected between animals. Needle reuse during vaccinations or treatments represents a particularly efficient transmission route, with a single contaminated needle potentially infecting dozens of animals in sequence.

The pathophysiology of eperythrozoonosis involves both direct red blood cell damage and immune-mediated destruction. Mycoplasma suis attaches to erythrocyte membranes, inducing conformational changes that expose normally hidden antigens. The pig's immune system recognizes these altered cells as foreign, producing antibodies that target infected erythrocytes for destruction in the spleen and liver. This extravascular hemolysis depletes red blood cell mass progressively, causing anemia proportional to the rate of cell destruction. The released hemoglobin is processed into bilirubin, causing the icterus characteristic of severe cases. Simultaneously, the bone marrow attempts compensatory red blood cell production, but this response often proves insufficient during acute infection.

Early warning signs of eperythrozoonosis often appear subtle and may be overlooked without careful observation. Affected pigs initially show reduced appetite and decreased activity compared to herdmates. A slight paleness of the skin, most easily observed on the ears, snout, and belly, may develop before other signs become apparent. Pigs in the early stages of infection may show mild temperature elevation and prefer to lie separately from the group. Feed consumption records may reveal a gradual decline in intake before obvious clinical signs manifest, making careful monitoring of production parameters valuable for early detection.

Symptoms in growing and finishing pigs typically present as progressive weakness and exercise intolerance. Affected animals breathe heavily after minimal exertion and lag behind when the group moves. The characteristic pallor of the skin and mucous membranes becomes increasingly evident as anemia progresses. Some pigs develop a yellowish tinge to the skin and sclera, indicating icterus from red blood cell breakdown products. Body condition deteriorates despite adequate feed availability, with affected pigs showing prominent spine and hip bones as muscle wasting occurs.

Behavioral changes accompanying eperythrozoonosis reflect the systemic nature of the disease. Infected pigs become listless and unresponsive to stimuli that normally elicit interest. They may stand with heads lowered and ears drooping, showing little reaction to feeding or the presence of caretakers. Social interactions decrease, and affected animals often position themselves at the periphery of groups or seek isolated resting areas. Sows may show reduced maternal behavior, paying less attention to their litters and allowing piglets to become chilled or fail to nurse adequately.

Physical examination findings correlate with the degree of anemia present. Heart rate increases as the cardiovascular system compensates for reduced oxygen-carrying capacity. A systolic heart murmur may be audible due to decreased blood viscosity. Respiratory rate elevates, and affected pigs may exhibit open-mouth breathing during stress. The spleen often enlarges as it works to remove damaged erythrocytes from circulation. Peripheral lymph nodes may show mild enlargement in some cases. Body temperature during acute infection typically rises to between 40 and 42 degrees Celsius, though chronically infected animals may remain afebrile.

Disease progression varies considerably between individuals and depends on factors including organism load, immune status, and concurrent stressors. Acute cases may deteriorate rapidly over several days, progressing from apparent health to severe anemia requiring emergency intervention. Chronic cases develop more slowly, with gradual worsening of pallor and condition over weeks. Subclinical carriers may show no obvious signs while serving as reservoirs for herd infection. Pregnant sows experiencing acute infection may abort or deliver weak piglets, while boars may show temporary fertility reduction due to fever effects on spermatogenesis.

Emergency symptoms requiring immediate veterinary intervention include sudden collapse, severe respiratory distress, and profound pallor indicating life-threatening anemia. Pigs with packed cell volumes below fifteen percent face imminent risk of death without aggressive supportive care. Pregnant sows showing signs of impending abortion or those with fever exceeding 42 degrees Celsius require urgent attention. Any pig exhibiting neurological signs including incoordination, circling, or seizures needs immediate evaluation, as these may indicate severe oxygen deprivation to the brain from profound anemia or concurrent conditions requiring differentiation from eperythrozoonosis.

Clinical examination provides initial diagnostic direction in suspected eperythrozoonosis cases. Veterinarians assess mucous membrane color, checking the conjunctiva, gums, and vulvar mucosa for pallor or icterus. Heart and lung auscultation reveals compensatory cardiovascular changes including tachycardia and murmurs associated with anemia. Temperature measurement identifies febrile animals, though normal temperature does not exclude infection. Physical condition scoring documents muscle wasting and overall body condition. The combination of anemia, fever, and icterus in pigs, particularly following stressful events, strongly suggests eperythrozoonosis and warrants confirmatory testing.

Diagnostic testing confirms eperythrozoonosis infection and assesses disease severity. Complete blood count reveals regenerative anemia with decreased red blood cell numbers, reduced hemoglobin concentration, and lowered packed cell volume. Examination of stained blood smears may reveal organisms attached to erythrocyte surfaces, appearing as small coccoid or ring-shaped structures, though sensitivity of direct microscopy varies with organism load. Polymerase chain reaction testing provides the most sensitive and specific detection method, identifying Mycoplasma suis DNA even in subclinical carriers. Serological testing detects antibodies but cannot distinguish active infection from previous exposure.

Differential diagnosis considers other conditions causing anemia and icterus in swine. Iron deficiency anemia affects young piglets and causes similar pallor but typically occurs in specific age groups and lacks the fever component. Porcine reproductive and respiratory syndrome virus infection may cause reproductive losses and respiratory signs but produces different hematologic patterns. Gastric ulceration causes hemorrhagic anemia with dark, tarry feces indicating gastrointestinal blood loss. Warfarin toxicosis from rodenticide exposure causes bleeding disorders with different clinical presentation. Leptospirosis produces icterus and fever but typically affects kidney function prominently.

Herd-level diagnostics help characterize infection prevalence and guide control strategies. Sampling representative animals from different age groups and production stages reveals infection distribution throughout the operation. Testing of replacement animals before introduction identifies potential new infection sources. Monitoring of production parameters including growth rates, feed efficiency, and reproductive performance may reveal subclinical disease impact even when individual animals appear healthy. Slaughter surveillance through examination of carcasses and collection of samples at processing provides additional epidemiological information about herd infection status and the effectiveness of control measures implemented.

Emergency treatment of severe eperythrozoonosis focuses on stabilizing critically affected animals while initiating antimicrobial therapy. Pigs with profound anemia may require reduced handling stress to prevent sudden death from cardiac decompensation. Moving severely affected animals minimally and providing quiet, comfortable housing reduces oxygen demands. Whole blood transfusion from healthy donor pigs may be considered for animals with life-threatening anemia, though this option remains impractical in most production settings. Intravenous fluid therapy supports circulation in dehydrated animals and helps maintain organ perfusion despite reduced oxygen-carrying capacity.

Medical management centers on antimicrobial therapy targeting Mycoplasma suis. Tetracycline antibiotics, including oxytetracycline and chlortetracycline, demonstrate effectiveness against this organism and remain the most commonly used treatment option. Injectable oxytetracycline provides rapid therapeutic levels for acutely ill animals, while oral tetracyclines administered through feed or water treat larger groups and provide extended coverage. Treatment duration typically spans five to seven days for injectable products and fourteen to twenty-one days for oral medications. Critically, all antimicrobial use in food-producing animals requires veterinary prescription and strict adherence to withdrawal periods before animals enter the food supply. Current withdrawal times for oxytetracycline range from fourteen to twenty-eight days depending on formulation and administration route.

Surgical intervention plays no role in eperythrozoonosis treatment, as the condition involves systemic blood cell infection rather than lesions amenable to surgical correction. However, attention to surgical technique during routine procedures helps prevent transmission. Using separate, sterile equipment for each animal or thorough disinfection between animals reduces blood-borne spread during processing activities. Needle-free injection systems eliminate one major transmission route when available and appropriate for the products being administered.

Supportive care addresses the metabolic consequences of hemolytic anemia and helps animals through the recovery period. Iron supplementation supports red blood cell regeneration, though iron should be administered cautiously in very young piglets to avoid iron toxicity. B-vitamin supplementation, particularly vitamin B12 and folic acid, supports erythropoiesis. Ensuring adequate high-quality nutrition provides building blocks for blood cell production. Climate control maintains thermal comfort, reducing metabolic demands when oxygen delivery is compromised. Protection from aggression by herdmates prevents additional stress and potential injury to weakened animals.

Herd treatment protocols address both clinical cases and subclinical carriers when infection affects multiple animals. Strategic medication of high-risk groups during stressful periods such as weaning, transport, or environmental changes may reduce clinical disease expression. Pulse treatment programs alternating treatment and withdrawal periods have been used to suppress organism levels while managing antimicrobial use. Treatment of sows during late gestation may reduce transmission to piglets, though complete elimination of infection from the herd through treatment alone is not achievable due to persistent carrier states.

Treatment decisions in commercial swine production balance animal welfare, economic considerations, and practical limitations. Individual treatment of high-value breeding animals typically receives priority, while market animal treatment decisions weigh recovery probability against production losses and medication costs. Severely affected animals with poor prognosis may be euthanized on welfare grounds rather than subjected to prolonged treatment with uncertain outcomes. Veterinary guidance helps producers navigate these decisions, considering both immediate animal welfare and longer-term herd health implications. Documentation of treatment decisions, protocols used, and outcomes supports continuous improvement in eperythrozoonosis management and ensures compliance with food safety requirements.

Recovery timeline for eperythrozoonosis varies considerably based on infection severity and promptness of treatment initiation. Mildly affected animals may show improvement within three to five days of antimicrobial therapy initiation, with appetite returning and activity levels normalizing. Moderately affected pigs typically require two to three weeks before packed cell volume returns to acceptable ranges and clinical signs fully resolve. Severely anemic animals face prolonged recovery periods extending four to six weeks or longer, with some never achieving full return to previous performance levels. Complete red blood cell regeneration requires adequate nutritional support throughout this extended recovery phase.

Post-treatment care and monitoring ensure continued progress and identify animals requiring additional intervention. Daily observation assesses appetite, activity, and clinical appearance during the initial recovery period. Weekly weight measurements document return to expected growth patterns. Follow-up blood testing at one and three weeks post-treatment confirms hematologic improvement and helps identify non-responsive cases requiring extended treatment or alternative diagnoses. Treated animals should be maintained in low-stress environments with good ventilation, appropriate temperature control, and ready access to feed and water throughout recovery.

Prognosis factors influencing recovery outcomes include initial disease severity, treatment timing, concurrent health challenges, and individual immune competence. Animals treated early in the disease course before profound anemia develops generally achieve excellent recovery with minimal lasting impact. Those with packed cell volumes below twenty percent at treatment initiation face guarded prognosis despite appropriate therapy. Concurrent infections, particularly respiratory disease, complicate recovery and worsen outcomes. Young animals and breeding stock in good body condition prior to infection typically recover more completely than older or previously compromised individuals.

Return to production considerations differ by animal class and production stage. Growing pigs recovering from clinical eperythrozoonosis may show permanent growth setbacks, affecting time to market weight and overall feed efficiency. Breeding sows recovering from periparturient infection may show reduced milk production affecting current litter performance, though subsequent reproductive cycles typically normalize. Boars experiencing fever during infection may show temporary semen quality reduction for eight to ten weeks reflecting the spermatogenic cycle duration. Importantly, recovered animals remain carriers of Mycoplasma suis and should be managed accordingly to prevent transmission to susceptible herdmates, with carrier status consideration in culling and replacement decisions.

No commercial vaccine currently exists for eperythrozoonosis, making management-based prevention strategies essential for controlling this disease. Research into vaccine development continues, with experimental vaccines showing some promise in reducing clinical disease severity, but no products have achieved commercial availability. In the absence of vaccination options, prevention focuses on reducing transmission opportunities, managing stressors that trigger clinical disease in carriers, and implementing biosecurity measures to prevent introduction of infection into naive herds. Autogenous vaccines prepared from organisms isolated from specific herds have been used in some situations but require careful veterinary oversight.

Biosecurity measures form the foundation of eperythrozoonosis prevention in uninfected herds. Sourcing replacement animals from negative herds and testing incoming stock before introduction prevents new infections. Quarantine periods of at least thirty days with testing before and after quarantine provide additional security. Perimeter fencing and facility design preventing contact with feral swine eliminate potential wildlife reservoirs. Visitor restrictions, dedicated clothing and footwear, and vehicle sanitation prevent mechanical introduction of infected blood. Staff training emphasizes the blood-borne nature of transmission and proper protocols to prevent inadvertent spread.

Nutritional prevention supports immune function and reduces disease susceptibility. Diets meeting all nutrient requirements for each production stage optimize immune competence. Adequate iron availability supports red blood cell production, helping animals compensate for subclinical infection-related cell loss. Antioxidant nutrients including vitamin E and selenium support cellular immunity. Avoiding nutritional stress during critical periods such as weaning, breeding, and late gestation reduces triggers for clinical disease expression in carrier animals. Feed quality monitoring ensures absence of mycotoxins that could suppress immune function and predispose to opportunistic infections.

Management practices targeting transmission routes significantly reduce infection spread within herds. Using individual needles for each animal or needle-free injection systems eliminates the most efficient transmission route during routine procedures. Disinfecting surgical instruments including castration equipment, ear notchers, and tail docking tools between animals prevents blood-borne spread during processing. Controlling biting insect and lice populations through environmental management and appropriate parasiticide use reduces vector transmission. Minimizing mixing of animal groups and maintaining stable social structures reduces fighting-related transmission through wounds.

Quarantine and testing protocols provide additional prevention layers for valuable breeding stock and when establishing new herds. Testing donor animals before blood transfusion prevents iatrogenic transmission. Embryo transfer recipients should be tested to prevent infection of valuable genetic material. Artificial insemination from tested-negative boars avoids potential venereal transmission. When eradicating infection from breeding herds, test and removal programs can progressively reduce carrier prevalence, though complete elimination requires rigorous testing protocols and willingness to remove valuable animals testing positive. Ongoing surveillance through periodic testing of representative animals confirms continued negative status and provides early warning of new introductions.

Daily management and monitoring protocols detect eperythrozoonosis problems early and track herd health status over time. Caretakers trained to recognize anemia signs including pallor, weakness, and respiratory changes identify affected individuals promptly. Walk-through observations assessing each group's overall demeanor, activity levels, and feed consumption occur at least twice daily. Individual animals showing concerning signs receive closer examination and potential diagnostic workup. Recording systems document observations, enabling pattern recognition that might reveal emerging herd health problems before they become widespread.

Housing and environmental management reduce transmission opportunities and disease expression. Solid partitions between pens minimize nose-to-nose contact and reduce aerosol transmission of concurrent pathogens. Adequate space allowances reduce aggression-related injuries that create transmission opportunities. Sanitation protocols emphasizing removal of blood and organic matter reduce pathogen persistence in the environment. Temperature management maintaining thermal comfort decreases metabolic stress on marginally affected animals. Ventilation systems providing fresh air without drafts support respiratory health and reduce overall disease pressure that could trigger clinical eperythrozoonosis in carriers.

Herd health programs incorporate eperythrozoonosis surveillance and control into comprehensive disease management. Regular veterinary visits review production records, examine sample animals, and assess biosecurity compliance. Diagnostic testing protocols specify which animals to test, testing frequency, and response actions based on results. Written health plans document standard procedures, treatment protocols, and responsible personnel for various health events. Integration with other disease control programs ensures eperythrozoonosis management complements rather than conflicts with control of other significant pathogens such as porcine reproductive and respiratory syndrome virus or Mycoplasma hyopneumoniae.

Record keeping and monitoring systems provide data supporting management decisions and enable continuous improvement. Individual animal health records track treatments administered, withdrawal dates, and outcomes achieved. Group performance records including mortality, growth rates, and feed efficiency reveal subclinical disease impacts. Diagnostic test results maintained over time show infection prevalence trends and control program effectiveness. Economic records documenting disease-related costs including treatment expenses, mortality losses, and reduced performance justify prevention investments and guide resource allocation priorities.

Economic considerations influence eperythrozoonosis management strategy selection and implementation intensity. Cost-benefit analysis compares prevention investments against expected disease losses given herd infection status. High-value seedstock operations typically implement more intensive surveillance and biosecurity than commercial finishing operations where individual animal value is lower. Treatment decisions balance medication costs and withdrawal period impacts against salvage value and welfare concerns. Market timing flexibility may allow holding recovered animals longer to achieve acceptable market weights despite disease-related growth setbacks. Insurance and indemnity program availability affects risk tolerance and management strategy selection for some operations facing eperythrozoonosis challenges.

Eperythrozoonosis affects all swine breeds without strong breed-specific susceptibility patterns, though management systems associated with certain breed types may influence exposure risk. High-health seedstock operations maintaining purebred breeding stock often implement more rigorous biosecurity, potentially reducing infection prevalence compared to commercial crossbred populations. Heritage breed pigs raised in extensive outdoor systems may face increased vector exposure from biting insects compared to confinement-raised commercial breeds. Breeds selected intensively for production traits without concurrent selection for disease resistance may show reduced overall immune competence, though specific susceptibility to Mycoplasma suis has not been documented.

Production type significantly influences eperythrozoonosis risk and impact. High-producing sow lines undergoing intensive reproductive cycles face repeated physiological stress that may trigger clinical disease in carriers. Fast-growing finishing pigs selected for rapid lean gain may show less metabolic reserve when challenged by infection. Conversely, slower-growing heritage breeds or those selected for hardiness may tolerate subclinical infection with less performance impact. Outdoor production systems expose pigs to environmental stressors and vectors potentially increasing clinical disease risk, while indoor systems may facilitate transmission through shared equipment if biosecurity lapses occur.

Genetic selection and testing offer potential tools for eperythrozoonosis management in breeding programs. Testing breeding candidates before selection identifies carriers that could introduce or perpetuate infection in nucleus herds. Culling positive animals from breeding populations progressively reduces infection prevalence over generations. While specific genetic markers for eperythrozoonosis resistance have not been identified, selection for overall immune competence and disease resilience may provide indirect benefits. Genomic selection programs increasingly incorporate health traits, potentially enabling future selection for reduced susceptibility to blood-borne pathogens including Mycoplasma suis as genetic understanding advances.

Several conditions commonly co-occur with eperythrozoonosis or share predisposing factors. Porcine reproductive and respiratory syndrome virus infection suppresses immune function and may trigger clinical eperythrozoonosis in previously subclinical carriers. Concurrent respiratory disease from Mycoplasma hyopneumoniae or bacterial pathogens compounds the respiratory compromise caused by anemia. Gastrointestinal parasitism causing chronic blood loss synergizes with eperythrozoonosis-induced hemolysis to produce more severe anemia than either condition alone. Nutritional deficiencies, particularly iron deficiency in young piglets, create additive anemia when combined with Mycoplasma suis infection.

Conditions producing similar clinical signs require differentiation from eperythrozoonosis for appropriate treatment selection. Other hemolytic conditions including babesiosis in regions where this parasite occurs and immune-mediated hemolytic anemia present comparable anemia and icterus. Hemorrhagic conditions including gastric ulceration, warfarin toxicosis, and thrombocytopenia cause anemia through blood loss rather than hemolysis. Hepatic disease from various causes produces icterus without the hemolytic pattern of eperythrozoonosis. Systemic infections with fever and depression including classical swine fever in endemic regions require exclusion given reportable disease implications.

Complications and sequelae of eperythrozoonosis extend beyond the acute disease period. Chronic carriers may experience recurrent clinical episodes during future stress events. Immune suppression during acute infection increases susceptibility to secondary bacterial infections including streptococcal septicemia and pneumonia. Reproductive losses including abortion, stillbirth, and weak piglet syndrome follow acute sow infection. Growth performance may never fully recover in severely affected pigs, creating permanent economic impact from a single disease episode. Organ damage from severe anemia, particularly cardiac and renal effects, may have lasting consequences in recovered animals intended for breeding purposes.